Overexpressed in several kinds of cancers, cyclin-dependent kinase inhibitor 3 (Cdkn3) dephosphorylates and prevents CDK2 kinase activation in a cyclin-dependent manner (Hannon et al. 1994; Yeh et al. 2000; Navis et al. 2010). Here, CDKN3 is linked to cancer.